Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefania Russo

Showing results (71-80 of 87) with videos related to

Pageof 9
Sort By:
NPJ Breast Cancer|December 18, 2024
Clinico-pathological predictors of radiologic complete response to first-line anti-HER2 therapy in metastatic breast cancerLinda Cucciniello, Eva Blondeaux, Claudia Bighin, et al.
Translational Oncology|June 27, 2025
Longitudinal profiling of hormone receptor positive, HER2 negative metastatic breast cancer through droplet digital PCR-based circulating tumor DNA fragmentomicsLorenzo Foffano, Alessandra Franzoni, Elisabetta Molteni, et al.
Journal of Cancer Research and Clinical Oncology|November 5, 2015
Demographic, tumor and clinical features of clinical trials versus clinical practice patients with HER2-positive early breast cancer: results of a prospective studyGrazia Arpino, Andrea Michelotti, Mauro Truini, et al.
NPJ Breast Cancer|June 29, 2021
Composite risk and benefit from adjuvant dose-dense chemotherapy in hormone receptor-positive breast cancerFabio Puglisi, Lorenzo Gerratana, Matteo Lambertini, et al.
Tumori|July 15, 2017
Physicists' views on hadrontherapy: a survey of members of the Italian Association of Medical Physics (AIFM)Tommaso Giandini, Chiara Tenconi, Mauro Carrara, et al.
Neuro-Oncology|March 21, 2020
Proton and carbon ion radiotherapy in skull base chordomas: a prospective study based on a dual particle and a patient-customized treatment strategyAlberto Iannalfi, Emma D'Ippolito, Giulia Riva, et al.
Neuro-Oncology|December 1, 2021
Corrigendum to: Proton and carbon ion radiotherapy in skull base chordomas: a prospective study based on a dual particle and a patient-customized treatment strategyAlberto Iannalfi, Emma D'Ippolito, Giulia Riva, et al.
Frontiers in Oncology|October 15, 2021
Dosimetric Impact of Inter-Fraction Anatomical Changes in Carbon Ion Boost Treatment for High-Risk Prostate Cancer (AIRC IG 14300)Stefania Russo, Rosalinda Ricotti, Silvia Molinelli, et al.
Breast Cancer Research and Treatment|February 16, 2021
The efficacy and safety of enzalutamide with trastuzumab in patients with HER2+ and androgen receptor-positive metastatic or locally advanced breast cancerAndrew Wardley, Javier Cortes, Louise Provencher, et al.
Tumori|April 26, 2021
Ultrahypofractionated radiotherapy for localized prostate cancer with simultaneous boost to the dominant intraprostatic lesion: a plan comparisonRaffaella Cambria, Delia Ciardo, Alessia Bazani, et al.
Pageof 9

Showing results (71-80 of 87) with videos related to

Sort By:
Pageof 9
NPJ Breast Cancer|December 18, 2024
Clinico-pathological predictors of radiologic complete response to first-line anti-HER2 therapy in metastatic breast cancerLinda Cucciniello, Eva Blondeaux, Claudia Bighin, et al.
Translational Oncology|June 27, 2025
Longitudinal profiling of hormone receptor positive, HER2 negative metastatic breast cancer through droplet digital PCR-based circulating tumor DNA fragmentomicsLorenzo Foffano, Alessandra Franzoni, Elisabetta Molteni, et al.
Journal of Cancer Research and Clinical Oncology|November 5, 2015
Demographic, tumor and clinical features of clinical trials versus clinical practice patients with HER2-positive early breast cancer: results of a prospective studyGrazia Arpino, Andrea Michelotti, Mauro Truini, et al.
NPJ Breast Cancer|June 29, 2021
Composite risk and benefit from adjuvant dose-dense chemotherapy in hormone receptor-positive breast cancerFabio Puglisi, Lorenzo Gerratana, Matteo Lambertini, et al.
Tumori|July 15, 2017
Physicists' views on hadrontherapy: a survey of members of the Italian Association of Medical Physics (AIFM)Tommaso Giandini, Chiara Tenconi, Mauro Carrara, et al.
Neuro-Oncology|March 21, 2020
Proton and carbon ion radiotherapy in skull base chordomas: a prospective study based on a dual particle and a patient-customized treatment strategyAlberto Iannalfi, Emma D'Ippolito, Giulia Riva, et al.
Neuro-Oncology|December 1, 2021
Corrigendum to: Proton and carbon ion radiotherapy in skull base chordomas: a prospective study based on a dual particle and a patient-customized treatment strategyAlberto Iannalfi, Emma D'Ippolito, Giulia Riva, et al.
Frontiers in Oncology|October 15, 2021
Dosimetric Impact of Inter-Fraction Anatomical Changes in Carbon Ion Boost Treatment for High-Risk Prostate Cancer (AIRC IG 14300)Stefania Russo, Rosalinda Ricotti, Silvia Molinelli, et al.
Breast Cancer Research and Treatment|February 16, 2021
The efficacy and safety of enzalutamide with trastuzumab in patients with HER2+ and androgen receptor-positive metastatic or locally advanced breast cancerAndrew Wardley, Javier Cortes, Louise Provencher, et al.
Tumori|April 26, 2021
Ultrahypofractionated radiotherapy for localized prostate cancer with simultaneous boost to the dominant intraprostatic lesion: a plan comparisonRaffaella Cambria, Delia Ciardo, Alessia Bazani, et al.
Pageof 9